share_log

TAAT Global Alternatives Inc. (OTCMKTS:TOBAF) Short Interest Down 43.5% in February

TAAT Global Alternatives Inc. (OTCMKTS:TOBAF) Short Interest Down 43.5% in February

TAAT Global Alternatives Inc.(OTCMKTS: TOBAF)2月份空头利率下降了43.5%
Financial News Live ·  2023/03/02 08:03

TAAT Global Alternatives Inc. (OTCMKTS:TOBAF – Get Rating) was the recipient of a significant drop in short interest in February. As of February 15th, there was short interest totalling 256,900 shares, a drop of 43.5% from the January 31st total of 455,000 shares. Based on an average daily trading volume, of 47,100 shares, the days-to-cover ratio is presently 5.5 days.

TAAT Global Alternatives Inc.(OTCMKTS: TOBAF — 获取评级)是2月份空头利息大幅下降的接受者。截至2月15日,空头利息总额为25.69万股,较1月31日的45.5万股下降了43.5%。根据47,100股的平均每日交易量,目前的回报天数比率为5.5天。

TAAT Global Alternatives Stock Performance

TAAT 全球另类股票表现

Shares of TAAT Global Alternatives stock opened at $0.33 on Thursday. TAAT Global Alternatives has a one year low of $0.22 and a one year high of $1.50. The company has a debt-to-equity ratio of 0.26, a quick ratio of 2.39 and a current ratio of 3.69. The company has a market cap of $35.33 million, a price-to-earnings ratio of -1.62 and a beta of 1.09. The business's 50 day moving average price is $0.34 and its 200 day moving average price is $0.50.

TAAT Global Alternatives股票周四开盘价为0.33美元。TAAT Global Alternatives的一年低点为0.22美元,一年来的最高点为1.50美元。该公司的债务与权益比率为0.26,速动比率为2.39,流动比率为3.69。该公司的市值为3533万美元,市盈率为-1.62,beta值为1.09。该公司的50天移动平均价格为0.34美元,其200天移动平均线价格为0.50美元。

Get
获取
TAAT Global Alternatives
TAAT 全球替代品
alerts:
警报:

TAAT Global Alternatives Company Profile

TAAT 全球另类投资公司简介

(Get Rating)

(获取评分)

TAAT Global Alternatives Inc is an early-stage life sciences company. It focuses on hemp and the association with health and fitness. Its product portfolio includes Hemp cigarettes. The company was founded on June 5, 2006 and is headquartered in Vancouver, Canada.

TAAT Global Alternatives Inc是一家早期生命科学公司。它侧重于大麻及其与健康和健身的关系。其产品组合包括大麻香烟。该公司成立于2006年6月5日,总部位于加拿大温哥华。

Further Reading

进一步阅读

  • Get a free copy of the StockNews.com research report on TAAT Global Alternatives (TOBAF)
  • Wall Street Sees 23% Upside In Revance, Maker Of Botox Competitor
  • Has Workhorse Group Finally Hit Bottom?
  • Target Offering A Rare Buying Opportunity After Earnings
  • Rivian Gives Investors a Taste of the Anxiety Its Consumers Feel
  • 3 High-Yield Dividend Stocks That Are Probably Not On Your Radar
  • 免费获取 StockNews.com 关于 TAAT 全球替代方案 (TOBAF) 的研究报告的副本
  • 华尔街认为肉毒杆菌毒素竞争对手Revance有23%的上涨空间
  • Workhorse 集团终于触底了吗?
  • Target 在盈利后提供难得的买入机会
  • Rivian 让投资者体会到其消费者所感受到的焦虑
  • 3 只可能不在你的关注范围内的高收益股息股票

Receive News & Ratings for TAAT Global Alternatives Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for TAAT Global Alternatives and related companies with MarketBeat.com's FREE daily email newsletter.

每日接收TAAT全球另类投资的新闻和收视率 -在下面输入您的电子邮件地址,通过Marketbeat.com的免费每日电子邮件时事通讯接收TAAT Global Alternates和相关公司的最新新闻和分析师评级的简明每日摘要。

声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发